Skip to main content
OpenTrials
Completed

NCT Number: NCT01929902

Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery

The purpose of this study is to test the efficacy and accuracy of the Aquamantys device.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Carolinas Healthcare System

Charlotte, North Carolina, 28204, United States

About this study

The primary objective of this study is to assess the efficacy of placement and accuracy of the Aquamantys device in 20 patients that require general surgery. High frequency electrosurgery is the application of frequency in the range of 300 kHz up to several MHz in order to coagulate or destroy tissue. Due to technological advancements, knowledge of how frequency and other physical modes interact with biological materials has become increasingly important in order for the surgeon to provide a safe and consistent surgery. The Aquamantys system utilizes radiofrequency energy and saline irrigation for cutting tissue and stopping excessive bleeding.

The Aquamantys system features the following:

  • Cone-shaped electrodes designed to aid blunt dissection;
  • Large bipolar electrode configuration allowing for hemostatic sealing across broad planes of tissue;
  • Bipolar electrodes alleviate the need for grounding pad;
  • Transcollation technology allows for controlled depth of energy penetration.

During surgery, the Aquamantys device will be utilized in order to stop excessive bleeding and to cut vessels. The patient will be monitored by the surgeon and research nurse coordinator before surgery, intra-operatively and post-operatively until discharge from the hospital. The study participant will follow-up post-operatively with the surgeon per standard of care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Indication for general surgery to include: liver resection and pancreatectomy
  • Male or females age 18 years of age or older

Exclusion criteria

  • Indication for emergency surgery
  • Suspected inability, e.g. language problems or the inability to comply with trial procedures
  • Employee at the investigational center, Sponsor or Sponsor's representative, relative or spouse of the investigator
  • Females who are pregnant or breastfeeding

Treatment and study plan

Primary outcomes

  1. Efficacy of the Aquamantys Device

    Time frame: 1 year

    Efficacy of device will be measured based on intra-operative and post-operative complication variables: estimated blood loss, blood transfusion, complications intra-operative and post-operative.

  2. Placement of Aquamantys Device

    Time frame: 1 year

    Evaluation of device placement will be measured based on vessel sealing variables: number of applications, vessel site, type of tissue to be sealed, number of failed and successful seals, tissue sticking, tissue color, thermal spread and desiccation.

Secondary outcomes

  1. Device Complications

    Time frame: 1 year

    Functional evaluation of device based on the variable: device malfunction.

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Collaborators

  • Medtronic

Registry information

Official study title

Laparoscopic Aquamantys Device in General Surgery: A Prospective Observational Study to Evaluate the Efficacy and Accuracy

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 28, 2013
Registry last updated
Apr 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.